ATE270332T1 - Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen - Google Patents

Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen

Info

Publication number
ATE270332T1
ATE270332T1 AT99946160T AT99946160T ATE270332T1 AT E270332 T1 ATE270332 T1 AT E270332T1 AT 99946160 T AT99946160 T AT 99946160T AT 99946160 T AT99946160 T AT 99946160T AT E270332 T1 ATE270332 T1 AT E270332T1
Authority
AT
Austria
Prior art keywords
basb033
polynucleotide
polypeptide
neisseria meningitidis
polypeptides
Prior art date
Application number
AT99946160T
Other languages
English (en)
Inventor
Jean-Louis Ruelle
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Application granted granted Critical
Publication of ATE270332T1 publication Critical patent/ATE270332T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99946160T 1998-09-14 1999-09-09 Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen ATE270332T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9820003.3A GB9820003D0 (en) 1998-09-14 1998-09-14 Novel compounds
PCT/EP1999/006718 WO2000015801A1 (en) 1998-09-14 1999-09-09 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses

Publications (1)

Publication Number Publication Date
ATE270332T1 true ATE270332T1 (de) 2004-07-15

Family

ID=10838842

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99946160T ATE270332T1 (de) 1998-09-14 1999-09-09 Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen

Country Status (14)

Country Link
US (4) US6627204B1 (de)
EP (1) EP1112366B1 (de)
JP (1) JP2002528057A (de)
CN (1) CN1245419C (de)
AT (1) ATE270332T1 (de)
AU (1) AU5862299A (de)
CA (1) CA2343314A1 (de)
DE (1) DE69918446T2 (de)
DK (1) DK1112366T3 (de)
ES (1) ES2226438T3 (de)
GB (1) GB9820003D0 (de)
HK (1) HK1038041A1 (de)
PT (1) PT1112366E (de)
WO (1) WO2000015801A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4812942B2 (ja) * 1999-02-26 2011-11-09 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル ＣＧモチーフを含むオリゴヌクレオチドを用いるＮｅｉｓｓｅｒｉａ抗原殺菌活性の増強
NO20002828D0 (no) * 2000-06-02 2000-06-02 Statens Inst For Folkehelse Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
GB0103424D0 (en) * 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
EP2255826B1 (de) 2002-08-02 2016-04-13 GlaxoSmithKline Biologicals S.A. Neisseria impfstoffzusammensetzungen die eine kombination von antigenen enthalten
GB2414667A (en) * 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
US9475864B2 (en) * 2008-09-05 2016-10-25 University Of Massachusetts Methods, compositions and vaccines relating to Neisseria meningitidis antibodies
CN103002910A (zh) 2010-03-10 2013-03-27 葛兰素史密丝克莱恩生物有限公司 疫苗组合物
AU2013214105A1 (en) 2012-02-02 2014-07-24 Novartis Ag Promoters for increased protein expression in meningococcus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751000B1 (fr) * 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques

Also Published As

Publication number Publication date
DK1112366T3 (da) 2004-11-01
EP1112366A1 (de) 2001-07-04
CN1245419C (zh) 2006-03-15
DE69918446T2 (de) 2005-07-28
US20080219986A1 (en) 2008-09-11
US7071321B2 (en) 2006-07-04
US6627204B1 (en) 2003-09-30
ES2226438T3 (es) 2005-03-16
DE69918446D1 (de) 2004-08-05
CN1326508A (zh) 2001-12-12
WO2000015801A1 (en) 2000-03-23
US20030224012A1 (en) 2003-12-04
EP1112366B1 (de) 2004-06-30
HK1038041A1 (en) 2002-03-01
US20050272091A1 (en) 2005-12-08
PT1112366E (pt) 2004-11-30
AU5862299A (en) 2000-04-03
GB9820003D0 (en) 1998-11-04
JP2002528057A (ja) 2002-09-03
CA2343314A1 (en) 2000-03-23

Similar Documents

Publication Publication Date Title
DE69928658D1 (de) Basb029 polynucleotide und polypeptide aus neisseria meningitis
WO1999055873A3 (en) Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
ATE270332T1 (de) Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen
PL345793A1 (en) Neisseria meningitidis
DE60134253D1 (de) Basb205 polypeptide und dafür kodierende polynukleotide
WO2000043519A3 (en) Neisseria meningitidis polypeptides
ATE443715T1 (de) Polypeptide aus haemophilus influenza
ATE527360T1 (de) Neue verbindungen abgeleitet von neisseria meningitidis
DE60043658D1 (de) Basb118 polypeptid und polynukleotid aus moraxella catarrhalis
ATE360073T1 (de) Basb119 polypeptid und polynukleotid aus moraxella catarrhalis
ATE311458T1 (de) Basb111 polypeptid und polynukleotid aus moraxella catharralis
ATE399205T1 (de) Immunogene polypeptide aus moraxella catarrhalis und deren verwendungen
ATE515511T1 (de) Nicht-typisierbare haemophilus influenzae basb201 polypeptide und polynukleotide und deren verwendungen
DE69919693D1 (de) Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis
DE60019614D1 (de) Moraxella catarrhalis antigen basb117
DE60035788D1 (de) Polypeptide aus moraxella (branhamella) catarrhalis
ATE293692T1 (de) Moraxella catarrhalis antigen basb120

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1112366

Country of ref document: EP